FindTrial
Sign In

Striae Gravidarum(Stretch marks during pregnancy):A Randomised Control trial of Patoladi cream

Striae Gravidarum(Garbhini Kikkisa):A Randomised Control trial of Patoladi cream - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099262
Enrollment
20
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Radhika Rajendra Kakade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal subject between 18-40 years Subject having pregnancy between 24-36 weeks Primi gravidae exhibiting features of Kikkisa patients from all socioeconomic classes

Exclusion criteria

Exclusion criteria: Striae present beforepregnancy known allergy to any component of the intervention high risk pregnancy(eg preeclampsia,gestational diabetes,eclampsia) major systemic illness such as diabetes mellitus,thyroid,cushings syndrome) presence of active skin infections or shronic dermatological disorders)

Design outcomes

Primary

MeasureTime frame
improvement in symptoms of kikkisa-itching and burning and discolouration Reduction in length and width of lesionTimepoint: Followup after 15 days and 30 days—

Secondary

MeasureTime frame
Observation of side effects if any Any untoward effect will be observedTimepoint: Followup after 15 days and 30 days—

Countries

India

Contacts

Public ContactDr Satish Khatal

College of Ayurved,Bharati vidyapeeth(Deemed to be)Pune 43

satish.khatal@bharatividyapeeth.edu9970282066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026